1. Cell Cycle/DNA Damage Metabolic Enzyme/Protease Immunology/Inflammation NF-κB Apoptosis
  2. Topoisomerase Reactive Oxygen Species Apoptosis Survivin Bcl-2 Family IAP DNA/RNA Synthesis
  3. Topoisomerase I inhibitor 17

Topoisomerase I inhibitor 17 (Compound 7h) 是一种 Topoisomerase I (Top1) 抑制剂。Topoisomerase I inhibitor 17 减少 DDX5,并逆转 DDX5 对 Top1 活性的锁定。Topoisomerase I inhibitor 17 诱导 Top1 介导的 DNA 损伤,促进 活性氧 (ROS) 产生。Topoisomerase I inhibitor 17 诱导凋亡 (减少抗凋亡蛋白 XIAP, Bcl-2, Survivin 且增加促凋亡蛋白Bax, γH2AX)。Topoisomerase I inhibitor 17 还阻止 G2/M 检查点的进展,诱导细胞周期阻滞。Topoisomerase I inhibitor 17 显著抑制结直肠癌细胞集落形成和细胞迁移的能力。Topoisomerase I inhibitor 17 有效减少人 PDX 肿瘤小鼠肿瘤。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

Topoisomerase I inhibitor 17 Chemical Structure

Topoisomerase I inhibitor 17 Chemical Structure

CAS No. : 2413582-45-1

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

查看 Topoisomerase 亚型特异性产品:

查看 Bcl-2 Family 亚型特异性产品:

查看 IAP 亚型特异性产品:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Topoisomerase I inhibitor 17 (Compound 7h) is a Topoisomerase I (Top1) inhibitor. Topoisomerase I inhibitor 17 reduces DDX5 and reverses the locking of Top1 activity by DDX5. Topoisomerase I inhibitor 17 induces Top1-mediated DNA damage and promotes reactive oxygen species (ROS) production. Topoisomerase I inhibitor 17 induces Apoptosis (reduces antiapoptotic proteins XIAP, Bcl-2, Survivin and up-regulates pro-apoptotic proteins Bax, γH2AX). Topoisomerase I inhibitor 17 also blocks the progression of the G2/M checkpoint and induces cell cycle arrest. Topoisomerase I inhibitor 17 significantly inhibits colony formation and cell migration in colorectal cancer cells. Topoisomerase I inhibitor 17 effectively reduces tumors in human PDX tumor mice[1].

IC50 & Target[1]

Bax

 

Bcl-2

 

Top1

 

XIAP

 

体外研究
(In Vitro)

Topoisomerase I inhibitor 17 (5-500 nM, 72 h) 对四种癌细胞 (HepG2、A549、HeLa 和 HCT116) 抗增殖,其 IC50 分别为 136.6, 33.7, 72.9 和 36.1 nM[1]
Topoisomerase I inhibitor 17 可穿过 Caco-2 细胞单层,从顶端到基底侧的表观渗透系数为 2.24 μcm/s (0.5-1.0 μM, 4 h),Caco-2 细胞的存活率超过 90% (0.2-1.0 μM, 4 h)[1]
Topoisomerase I inhibitor 17 (5-100 nM, 12-72 h) 显著抑制增殖诱导的集落形成,浓度依赖性抑制 HCT116 细胞迁移,增加 ROS 生成[1]
Topoisomerase I inhibitor 17 (0-50 μM, 48 h) 以剂量依赖性方式诱导 HCT116 细胞凋亡和细胞周期停滞,阻止 G2/M 检查点的进展[1]
Topoisomerase I inhibitor 17 抑制 HCT116 细胞中的 DDX5 表达 (100 μM, 48-72 h),解除 DDX5 阻断的 Top1 活性 (5 和 50 μM)[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Cycle Analysis[1]

Cell Line: HCT116
Concentration: 0, 2.5, 10, 50 nM
Incubation Time: 48 h
Result: Halted the progression of the G2/M checkpoint, resulted in a significant accumulation of cells at this critical pre-division stage, with increases in cell number observed at G2/M phases of 2.05% (0 nM), 33.48% (2.5 nM), 55.28% (5 nM) and 64.01% (10 nM), respectively.

Apoptosis Analysis[1]

Cell Line: HCT116
Concentration: 50, 100 nM
Incubation Time: 72 h
Result: Reduced expression of anti-apoptotic proteins (e.g. Survivin).
Upregulated the pro-apoptotic proteins Bax and γH2AX in a dose-dependent manner.
体内研究
(In Vivo)

Topoisomerase I inhibitor 17 (2-15 mg/kg, i.p., 一周一次,持续 4 周) 通过浓度依赖性的肿瘤抑制作用和可接受的毒性,有效减少人结肠癌 PDX 肿瘤小鼠的肿瘤[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: FL118 colorectal cancer (CRC) patient-derived xenograft (PDX) tumors models using a limited number of severe combined immunodeficiency (SCID) mice[1]
Dosage: 2, 8 and 15 mg/kg
Administration: Intraperitoneal injection (i.p.)
Result: Regressed CRC PDX27454 tumors after 21 days with no recurrence within 35 days through a concentration-dependent tumor-suppressive effect and acceptable toxicity at 15 mg/kg.
Displayed stable mouse body weights.
分子量

516.47

Formula

C28H21FN2O7

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Topoisomerase I inhibitor 17
目录号:
HY-168739
需求量: